Identifying drug response and disease susceptibility in individuals revolves around the identification of single nucleotide polymorphisms (SNPs) or changes to single bases within genes ...

Only a subset of single-nucleotide polymorphisms (SNPs) can be genotyped in genome-wide association studies. Imputation methods can infer the alleles of 'hidden' variants and use those inferences ...

Parnassus Core Equity Fund highlighted stocks like Synopsys, Inc. (NASDAQ:SNPS), in the third quarter 2024 investor letter. Synopsys, Inc. (NASDAQ:SNPS) offers electronic design automation ...

Both companies will have to divest some assets of course. Ansys will part ways with PowerArtist software and SNPS will be getting rid of its optic and photonics software. While I won’t be going ...

Synopsys (SNPS) closed at $492.89 in the latest trading session, marking a -1.81% move from the prior day. The stock's change was less than the S&P 500's daily loss of 1.54%. Elsewhere ...

Synopsys (SNPS) closed the latest trading day at $525.48, indicating a -0.17% change from the previous session's end. The stock exceeded the S&P 500, which registered a loss of 0.51% for the day.

In a report released yesterday, Joseph Quatrochi from Wells Fargo maintained a Hold rating on Synopsys (SNPS – Research Report), with a price ...